ClinicalRM Formation by Ms. Vicki Tifft
Since our founding in 1994, ClinicalRM has been committed to helping solve global health issues by providing flexible and expedient research solutions to the Federal Government, the Department of Defense, and commercial sponsors. Our determination was born out of on-the-ground experience. ClinicalRM founder and CEO, Victoria (Vicki) Tifft, served in the US Peace Corps as an infectious disease biologist. While in Africa, she experienced first-hand the devastating conditions people of developing nations endure and witnessed the overwhelming effects of infectious diseases, contracting malaria herself three times. Upon returning to the US, Ms. Tifft joined the Walter Reed Army Institute of Research (WRAIR) and the United States Army Medical Research Institute for Infectious Disease (USAMRIID). She played a major role in establishing the WRAIR Clinical Trials Center (CTC).
Building on the experience she gleaned working alongside military and government researchers throughout the US Army Medical Research and Materiel Command (USAMRMC), Ms. Tifft founded ClinicalRM in 1994. In our first two decades of business, ClinicalRM grew steadily through word of mouth and a reputation for outstanding work. We have been continuously recognized for successfully managing FDA-regulated basic, applied, and clinical research programs for the Army, Navy, and Air Force, as well as the National Institutes of Health (NIH). We have an increasing impact in the bioscience industry, working with commercial customers, academic partners, and a growing network of worldwide affiliates to ease the burden of global health crises through the provision of clinical solutions.
ClinicalRM Acquisition by ICON, plc.
In 2016, the scope of our services, capacity, and reach grew exponentially with our acquisition by ICON, plc, a global provider of outsourced drug development services to biopharma, medical device, government, biosimilar, and generic organizations. By combining our expertise in government-sponsored research with ICON’s breadth of services and global footprint, we provide a wider variety of services and thought leadership to our customers, providing solutions for more innovative drug development. We are part of the only full service CRO network that offers the knowledge, software, and systems for adaptive trials.